oral glp-1 for weight loss Patients taking an experimental drug lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other No injections 3 Takeaways from the Landmark

sales in 2025 alone, while the company continued to strengthen its position through geographic expansion and label enhancements

While early research is promising, some scientists caution it is still preliminary and could fuel unrealistic hopes GLP-1s will serve as a miraculous cure for addictive behaviors

Even though there are studies showing an effective and safe reduction of glycaemic parameters with initial combination therapies with DPP-4 inhibitors, initial combinations are not generally recommended in the new treatment recommendations (7072, 7685)

Breastfeeding on Ozempic or Mounjaro: Is Semaglutide or Tirzepatide Safe

Studies have shown that these triple agonists are more effective in reducing body weight and improving glucose control compared to mono- or dual-incretin receptor agonists

This is not usually captured in scientific awards, such as the Nobel Prize, which tend to be selective in who gets honoured